Similarly, the AG/AA patients were predominantly high stage (80.8%), with adenocarcinoma histology (70.2%), former or never smoking habit (66.0%), ECOG-PS of 0 (51.1%) and a wild-type status of KRAS (80.8%). The gene discussed is KRAS; the disease is adenocarcinoma.